Dr. Pail is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
New York, NY 10016Phone+1 212-263-5506
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 2017 - 2020
Weill Cornell MedicineClass of 2016
Certifications & Licensure
NY State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 168 citationsEx vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.Viktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, Joelle Tchinda, Samuel H. Dunn
Blood. 2017-03-16 - 5 citationsFinancial toxicity in patients with leukemia undergoing hematopoietic stem cell transplantation: A systematic review.Orrin Pail, Thomas G Knight
Best Practice & Research. Clinical Haematology. 2023-06-01 - 26 citationsCheckpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.Nicole A. Carreau, Orrin Pail, Philippe Armand, Reid W. Merryman, Ranjana H. Advani
The Oncologist. 2020-10-01
Lectures
- Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
